Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Cancer-associated thrombotic microangiopathy.

Govind Babu K, Bhat GR.

Ecancermedicalscience. 2016 Jun 28;10:649. doi: 10.3332/ecancer.2016.649. Review.

2.

Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations.

Murugapandian S, Bijin B, Mansour I, Daheshpour S, Pillai BG, Thajudeen B, Salahudeen AK.

Case Rep Nephrol Dial. 2015 Jun 26;5(2):160-7. doi: 10.1159/000435807.

3.

Drug-induced glomerular disease: direct cellular injury.

Markowitz GS, Bomback AS, Perazella MA.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1291-9. doi: 10.2215/CJN.00860115. Review.

4.

Nephrotoxicity of recent anti-cancer agents.

Lameire N.

Clin Kidney J. 2014 Feb;7(1):11-22. doi: 10.1093/ckj/sft135. Review.

5.

Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center.

Izzedine H, Escudier B, Lhomme C, Pautier P, Rouvier P, Gueutin V, Baumelou A, Derosa L, Bahleda R, Hollebecque A, Sahali D, Soria JC.

Medicine (Baltimore). 2014 Nov;93(24):333-9. doi: 10.1097/MD.0000000000000207. Erratum in: Medicine (Baltimore). 2014 Nov;93(24):414.

6.

Gemcitabine induced hemolytic uremic syndrome.

Sadjadi SA, Annamaraju P.

Am J Case Rep. 2012;13:89-91. doi: 10.12659/AJCR.882858.

7.

A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.

Hong DS, Choe JH, Naing A, Wheler JJ, Falchook GS, Piha-Paul S, Moulder SL, George GC, Choe JM, Strauss LC, Gallick GE, Kurzrock R.

Invest New Drugs. 2013 Aug;31(4):918-26. doi: 10.1007/s10637-012-9898-3.

8.

Digital ischemic events related to gemcitabine: Report of two cases and a systematic review.

Kuhar CG, Mesti T, Zakotnik B.

Radiol Oncol. 2010 Dec;44(4):257-61. doi: 10.2478/v10019-010-0020-1.

9.

Thrombotic microangiopathy with targeted cancer agents.

Blake-Haskins JA, Lechleider RJ, Kreitman RJ.

Clin Cancer Res. 2011 Sep 15;17(18):5858-66. doi: 10.1158/1078-0432.CCR-11-0804. Review.

10.

Thrombotic thrombocytopenic purpura and gemcitabine.

Kasi PM.

Case Rep Oncol. 2011 Jan;4(1):143-8. doi: 10.1159/000326801.

11.

Acute Fatal Liver Toxicity under Erlotinib.

Schacher-Kaufmann S, Pless M.

Case Rep Oncol. 2010 Jun 8;3(2):182-188.

Items per page

Supplemental Content

Support Center